#vaginal

The insert contained the antiretrovirals tenofovir alafenamide, known as TAF, and Vitekta (elvitegravir).

Previous studies have found that certain vaginal microbiome compositions are associated with greater HIV rates among women.

An anti-HIV vaginal microbicide gel lowered risk among women with a healthier dominant bacterial population.

Non-daily-dosing for PrEP offer high protection against HIV infection through anal sex, while vaginal sex protection is up for debate.

Greater dosing of Viread or Truvada as PrEP is needed to reach effective levels in vaginal and cervical tissue than in rectal tissue.

While many lubricants may irritate vaginal and rectal tissues, they don’t increase risk of HIV transmission—at least in test tube experiment

A new clinical trial of a novel drug-infused vaginal microbicide ring to prevent male-to-female transmission of HIV has opened in 17 clinical...

HIV prevention efforts have suffered a major setback following a Microbicide Trials Network (MTN) announcement that a vaginal gel containing t...

South African epidemiologist Salim Abdool Karim and his wife Quarraisha Abdool Karim will receive the inaugural Olusegun Obasanjo Prize from t...

The Centers for Disease Control and Prevention (CDC) advisory panel on vaccines has recommended that boys and young men be vaccinated...

May 18 is HIV Vaccine Awareness Day, an annual observance in recognition of the advocates and researchers who are working together to find a s...

Conrad, a nonprofit scientific organization based in Arlington, Virginia, and dedicated to reproductive health, has announced that the...

The New York State Department of Health AIDS Institute has published new guidelines on menstrual disorders in HIV-positive women. The guidelin...

A vaginal microbicide gel meant to protect women from HIV was found to be safe but ineffective in clinical trials, reports Agence France Press...

We know now that a tenofovir microbicidal gel can reduce HIV transmission in women by up to 54 percent and herpes simplex virus (HSV2) by abou...

Test trial looks to see if vaginal gels, films and contraceptive-style rings made with an antiretroviral medication will be effective.